Emerging disease information at your fingertips.

Provider
Resources

Recent Articles

→

Kitsap Respiratory Illness Report: Nov. 12 to Nov. 18

Click here to access week 46 of the Kitsap Respiratory Illness Report. In the week ending on Nov. 18, Kitsap Public Health District saw increasing numbers of labs positive for respiratory syncytial virus (RSV) and influenza reported by our sentinel respiratory reporting laboratories, indicating that RSV and flu are rising locally. Local COVID-19 indicators remain low.…
Health Advisory: Nirsevimab supplies limited

Nov. 22, 2023 Washington is scheduled to receive 7,700 50 mg and 600 100 mg Pfizer nirsevimab doses for the remainder of respiratory syncytial virus (RSV) season. The CDC released a Health Alert that provides guidance for healthcare providers. See the background section below for details. ACTIONS REQUESTED Immunize.org released a standing order template for this RSV season to ensure…

Health Advisory: Nirsevimab supplies limited

Nov. 22, 2023 Washington is scheduled to receive 7,700 50 mg and 600 100 mg Pfizer nirsevimab doses for the remainder of respiratory syncytial virus (RSV) season. The CDC released a Health Alert that provides guidance for healthcare providers. See the background section below for details. ACTIONS REQUESTED Immunize.org released a standing order template for this RSV season to ensure…
Kitsap Respiratory Illness Report: Nov. 12 to Nov. 18

Click here to access week 46 of the Kitsap Respiratory Illness Report. In the week ending on Nov. 18, Kitsap Public Health District saw increasing numbers of labs positive for respiratory syncytial virus (RSV) and influenza reported by our sentinel respiratory reporting laboratories, indicating that RSV and flu are rising locally. Local COVID-19 indicators remain low.…
Kitsap Respiratory Illness Report: Nov. 5 to Nov. 11

Click here to access week 45 of the Kitsap Respiratory Illness Report. In the week ending Nov. 11, Kitsap Public Health District saw increasing numbers of labs positive for influenza and respiratory syncytial virus (RSV) reported by our sentinel respiratory reporting laboratories, indicating that flu and RSV are rising locally. Local COVID-19 indicators remain low. 1.3%…